Legend Biotech (LEGN) EV to EBIT (2020 - 2026)

Legend Biotech (LEGN) EV to EBIT (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EV to EBIT
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -846,807.28
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -155,086.11
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -34,369.83
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 680.06
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 24.47
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 16.76
7 Belite Bio 62.72 Bn 62.72 Bn - -3.56
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 31.44
9 Revolution Medicines 37.35 Bn 37.35 Bn - -26.93
10 Legend Biotech 7.11 Bn 6.46 Bn 129.70 Mn 36.27

Historic Data

Download Data
DateValue
Jul 23, 2026 -26.20
Jul 22, 2026 -26.20
Jul 21, 2026 -26.21
Jul 20, 2026 -25.80
Jul 17, 2026 -24.62
Jul 16, 2026 -25.18
Jul 15, 2026 -25.59
Jul 14, 2026 -28.86
Jul 13, 2026 -28.96
Jul 10, 2026 -30.61
Jul 9, 2026 -30.99
Jul 8, 2026 -31.59
Jul 7, 2026 -31.36
Jul 6, 2026 -31.81
Jul 2, 2026 -34.13
Jul 1, 2026 -34.10
Jun 30, 2026 -32.85
Jun 29, 2026 -33.48
Jun 26, 2026 -32.61
Jun 26, 2026 -32.61